Lagerstandorte

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

Moxifloxacin Related Compound G (Hydrochloride Monohydrate)

● Auf Lager

Katalog-Nr.::	VE006991
CAS-Nr.::	N/A
Summenformel::	C21H27ClFN3O5
Molare Masse::	455.91 g/mol

Angebot anfordern

Zur RFQ-Liste hinzufügen

Zusätzliche Informationen zu Moxifloxacin Related Compound G (Hydrochloride Monohydrate)

Parent drug

Moxifloxacin

IUPAC-Name

1-Cyclopropyl-6-fluoro-8-methoxy-7-[(4aR, 7aR)-octahydro-6H-pyrrolo[3, 4-b]pyridin-6-yl]-4-oxo-1, 4-dihydroquinoline-3-carboxylic acid hydrochloride monohydrate

Pharmakopöe-Synonyme

N/A

Other Synonyms

Moxifloxacin(R,R)-Isomer/ (4aR,7aR)-Moxifloxacin / ent-Moxifloxacin / d-Moxifloxacin(hydrochloride monohydrate)

Smile

O=C(C1=CN(C2CC2)C3=C(C=C(F)C(N(C4)CC5C4CCCN5)=C3OC)C1=O)O.[H]Cl.[H]O[H]

InChI

InChI=1S/C21H24FN3O4.ClH.H2O/c1-29-20-17-13(19(26)14(21(27)28)9-25(17)12-4-5-12)7-15(22)18(20)24-8-11-3-2-6-23-16(11)10-24;;/h7,9,11-12,16,23H,2-6,8,10H2,1H3,(H,27,28);1H;1H2

Beschreibung

Moxifloxacin Related Compound G (Hydrochloride Monohydrate) is a meticulously characterized reference material that complies with rigorous regulatory requirements, including those defined by USP, EMA, JP, and BP. This product plays a crucial role in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial manufacturing of Moxifloxacin. It is further supported by a detailed Structure Elucidation Report (SER), ensuring high accuracy and reliability across a broad range of analytical applications.“